The future of healthcare systems. Method for rigorously assessing cost effectiveness of new drugs must be set up

BMJ. 1997 Oct 11;315(7113):953.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cost-Benefit Analysis
  • Delivery of Health Care / trends*
  • Drug Costs*
  • Forecasting
  • Humans
  • State Medicine / trends
  • United Kingdom